KRISTEN RESETAR: Open Payments
NPI 1912378407 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,075 in 128 payments from 19 companies in 2025. Trend: 2023 $1,891 · 2024 $2,381 · 2025 $3,075
Food & beverage: $2,324Travel & lodging: $751
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 9 | $1,246 |
| ABBVIE INC. | 64 | $831 |
| PFIZER INC. | 23 | $274 |
| Lilly USA, LLC | 8 | $137 |
| JAZZ PHARMACEUTICALS INC. | 6 | $132 |
| GENZYME CORPORATION | 2 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Lundbeck LLC | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
Products named: VNS Therapy, QULIPTA, NURTEC ODT, UBRELVY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, KISUNLA, EPIDIOLEX, BOTOX.
Industry payments across NY — which companies pay providers there.
